今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1729次   下载 1467 本文二维码信息
码上扫一扫!
分享到: 微信 更多
表儿茶素及其衍生物表儿茶素没食子酸酯通过MAPK-ERK44/42通路抑制前列腺间质细胞增殖
焦婵媛, 景春晖, 员小婷, 苗琳
天津中医药大学, 天津市现代中药重点实验室, 方剂学教育部重点实验室, 天津 300193
摘要:
[目的]探究锁阳中表儿茶素(EC)及其衍生物表儿茶素没食子酸酯(ECG)对前列腺间质细胞WPMY-1增殖的影响及其机制。[方法]体外培养WPMY-1细胞,加入不同剂量的ECG和EC,用噻唑蓝(MTT)法检测对细胞增殖的影响,用聚合酶链反应(PCR)和蛋白免疫印迹(Western blotting)法检测对增殖相关抗原PCNA mRNA和蛋白水平表达的影响;用Western blotting法分别检测ECG和EC对MAPK通路ERK44/42、P38、SAPK/JNK激活的抑制作用;加入ERK44/42激动剂C6-Ceramide (C6)及P38、SAPK/JNK联合激动剂Anisomycin (ANI)后,用MTT法检测对ECG和EC抑制细胞增殖的影响。[结果]1 nmol/L至10 μmol/L的ECG和EC均可以明显抑制WPMY-1细胞的增殖(P<0.01)。10 nmol/L的ECG和EC可以明显抑制WPMY-1细胞中PCNA mRNA和蛋白水平的表达(P<0.05)。ECG和EC均能抑制ERK44/42和SAPK/JNK的磷酸化,但对P38的磷酸化作用不明显;加入C6后,ECG和EC抑制WPMY-1增殖的能力明显降低(P<0.05或P<0.01),加入ANI后,则细胞增殖能力改变不明显。[结论]ECG和EC通过ERK44/42抑制前列腺间质细胞增殖,这可能是其抗良性前列腺增生的重要机制之一。
关键词:  表儿茶素没食子酸酯  表儿茶素  良性前列腺增生  细胞增殖  MAPK通路
DOI:10.11656/j.issn.1672-1519.2017.03.15
分类号:
基金项目:国家自然科学基金青年科学基金项目(81303293);天津市应用基础及前沿技术研究计划青年基金项目(14JCQNJC13400)。
Epicatechin and its derivate Epicatechin gallate inhibit prostatic stromal cell proliferation through selective MAPK-ERK44/42 pathway
JIAO Chan-yuan, JING Chun-hui, YUAN Xiao-ting, MIAO Lin
Tianjin Universiry of Traditional Chinese Medicine, Tianjin State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae of Ministry of Education, Tianjin 300193, China
Abstract:
[Objective] To study the effect and mechanism of Epicatechin (EC) and its derivate Epicatechin gallate (ECG) in cynomorium songaricum on the proliferation of prostrate stromal cell line WPMY-1.[Methods] WPMY-1 cells were treated with different doses of ECG and EC in vitro. MTT assay was performed to detect the effects of ECG and EC on WPMY-1 cell proliferation. PCR and western blot were performed to detect the mRNA and protein expressions of proliferating cell nuclear antigen proliferating cell nuclear antigen(PCNA) separately in WPMY-1 cells treated with ECG or EC. The phosphorylation levels of MAPK signaling pathway ERK44/42, P38, and SAPK/JNK were then detected by western blot in WPMY-1 cells after treatment with ECG or EC. The effects of different MAPK signalings on ECG and EC-suppressed cell proliferation were investigated in WPMY-1 cells after treatment with or without ERK44/42 agonist C6-Ceramide (C6) or dual agonist Anisomycin (ANI) of P38, SAPK/JNK.[Results] Both ECG and EC (1 nmol/L to 10 μmol/L) inhibited the proliferation of WPMY-1 cells significantly (P<0.01) and PCNA expressions in mRNA and protein levels in WPMY-1 cell(P<0.05). the constitutive phosphorylation levels of ERK44/42 and SAPK/JNK were significantly suppressed by ECG and EC, which of P38 was not altered. After the adding of C6 blocked ECG and EC-induced suppression of WPMY-1 cell proliferation(P<0.05 or P<0.01). The change of cell proliferation was not significant after the adding of ANI.[Conclusion] ECG and EC inhibit prostatic stromal cell proliferation through ERK44/42 pathway, which provides evidence for their mechanism on benign prostatic hyperplasia prevention.
Key words:  Epicatechin gallate  Epicatechin  benign prostatic hyperplasia  cell proliferation  MAPK pathway
关注公众号二维码